CHDI Foundation
clinical trials
Erik Lundgren
gene silencing
huntingtin lowering
Huntington's disease
Ionis Pharmaceuticals
IONIS-HTT-Rx
Lauren Boak
Mai-Lise Nguyen
Phase 3
RG6042
Roche
treatments
Roche Gears Upwards For Pivotal Stage Iii Huntington’S Illness Gene-Silencing Clinical Trial
Pharmaceutical giant Roche – currently without a timeline, but mindful of the urgency – is gearing upwards for the pivotal Phase 3 clinical trial of …